ResMed Buy Hold or Sell Recommendation

RMD -- USA Stock  

USD 107.03  0.90  0.83%

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding ResMed is 'Buy'. Macroaxis provides ResMed buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ResMed positions. The advice algorithm takes into account all of ResMed available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from ResMed buy-and-hold prospective. Additionally take a look at ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus.

Time Horizon

Risk Tolerance

Execute Advice

ResMed Current Recommendation



Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon ResMed has a risk adjusted performance of 0.01, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.2637 and treynor ratio of 0.0
Macroaxis provides advice on ResMed to complement and cross-verify current analyst consensus on ResMed. Our recommendation engine determines the corporation potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure ResMed is not overpriced, please check all ResMed fundamentals including its Book Value Per Share, Retained Earnings and the relationship between Cash per Share and Number of Employees . Given that ResMed has Price to Earning of 53.87 times, we recommend you check out ResMed market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

ResMed Thematic Classifications

Obamacare Repeal IdeaObamacare Repeal
Large healthcare related equities associated with Obamacare
Medical Equipment IdeaMedical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French
Drugs IdeaDrugs
Drug manufacturing and delivery

Returns Distribution Density

Mean Return0.23Value At Risk0.9
Potential Upside1.45Standard Deviation0.78
 Return Density 

Institutional Investors

Security TypeSharesValue
Vanguard Group IncCommon Shares14.5 M1.4 B
Capital World InvestorsCommon Shares11.7 M1.1 B
Blackrock IncCommon Shares11.2 M1.1 B
Fmr LlcCommon Shares8.1 M796.4 M
State Street CorpCommon Shares5.6 M552.8 M
Baillie Gifford CoCommon Shares4.9 M479.3 M
Geode Capital Management LlcCommon Shares1.8 M179.3 M

ResMed Greeks

Alpha over DOW
Beta against DOW=0.00
Overall volatility
Information ratio =0.29

ResMed Volatility Alert

ResMed has low volatility with Treynor Ratio of 0.0, Maximum Drawdown of 2.42 and kurtosis of 1.89. However, we advice all investors to further analyze ResMed to make certain all market information is desiminated and is consistent with the current expectations about ResMed upside potential.
 Better Than Average     
 Worse Than Average Compare ResMed to competition

ResMed Fundamental Vs Peers

FundamentalsResMedPeer Average
Return On Equity15.29 % (15.17) %
Return On Asset9.10 % (15.64) %
Profit Margin12.98 % (5.50) %
Operating Margin28.09 % (10.91) %
Current Valuation14.41 B152.14 B
Shares Outstanding142.74 M1.43 B
Shares Owned by Insiders1.14 % 6.91 %
Shares Owned by Institutions64.95 % 18.37 %
Price to Earning53.87 times40.69 times
Price to Book7.57 times14.44 times
Price to Sales6.96 times17.81 times
Revenue2.2 B9.85 B
Gross Profit1.2 B21.75 B
EBITDA616.88 M1.41 B
Net Income285.09 M517.71 M
Cash and Equivalents858.9 M3.89 B
Cash per Share6.01 times5.17 times
Total Debt1.02 B7.36 B
Debt to Equity50.40 % 0.72 %
Current Ratio1.29 times3.30 times
Book Value Per Share14.13 times13.64 times
Cash Flow from Operations174.38 M1.25 B
Earnings Per Share1.99 times2.30 times
Price to Earnings To Growth3.56 times1.22 times
Number of Employees6 K10.67 K
Market Capitalization15.28 B29.78 B
Total Asset3.26 B126.86 B
Retained Earnings2.16 B38.24 B
Working Capital781.73 M3.58 B
Current Asset1.42 B36.8 B
Current Liabilities637.99 M33.34 B
Z Score8.4708.73
   ResMed exotic insider transaction detected [view details]

ResMed Alerts

Trading Alerts and Improvement Suggestions
ResMed has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
About 65.0% of the company shares are owned by institutional investors
On May 9, 2018 ResMed paid $ 0.35 per share dividend to its current shareholders
Latest headline from MacroaxisInsider: ResMed exotic insider transaction detected

Did You Try This Idea?

Run Emerging Markets Thematic Idea Now
Emerging Markets
Emerging Markets Idea
Fund or Etfs that invest in markets of developing countries. Emerging Markets theme has 40 constituents.
View All  Next Launch Emerging Markets
Additionally take a look at ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.